Seminars in oncology nursing
-
To review the current status, recent advances and ongoing research efforts related to screening, diagnosis and staging, and treatment of non-small cell lung cancer (NSCLC). ⋯ An understanding of treatment modalities and new therapies for NSCLC will help nurses assist patients to make educated decisions about the potential risks and benefits of their therapeutic options.
-
To review current approaches to primary prevention of lung cancer and to screening for precarcinogenic or preclinical asymptomatic disease. ⋯ Nurses are in a strategic position to prevent smoking initiation and to influence successful smoking cessation through education, information on the multiple modalities to assist behavioral change, and ongoing reinforcement.
-
To review major events in cigarette marketing and smoking practices, and to examine courses of action that can be taken by nurses to impact public health and safety. ⋯ Any nurse can take positive action toward tobacco control in numerous ways: by increasing awareness of the need for tobacco control; initiating personal action such as education and contacting legislators; and supporting public action through joining groups or coalitions whose efforts are directed at tobacco control.
-
To provide an overview of hospice services provided, and hospices affiliated with home health agencies. ⋯ Hospice nurses must expand their scope of practice beyond the walls of the hospital and home to provide holistic nursing care in collaboration with staff from many disciplines. Hospice nurses need to provide support to the patient and family in achieving the quality of life of their choosing.
-
To examine the physiology of nausea, vomiting, and retching (NVR); the impact of NVR on the patient: current measures to control NVR; and selfcare interventions. ⋯ Continual assessment of the individual's symptom experience is imperative. Effective management of the symptom experience depends on the oncology nurses's ability to implement current knowledge of antiemetic, and other drugs; non-pharmacological interventions; and cost-effective and clinically useful patient outcomes.